Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Gene Expression Changes on the Ocular Surface Cellular Aging
Author Affiliations & Notes
  • Tianxiang Huang
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Takenori Inomata
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Koji Kitazawa
    Department of Ophthalmology, Kyoto Furitsu Ika Daigaku, Kyoto, Kyoto, Japan
  • Shokirova Hurramhon
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • yuki moroka
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • MAKO OKAMOTO
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Yuichi Okumura
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Maria Miura
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Keiichi Fujimoto
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Gaku Ishida
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Shintaro Nakao
    Department of Ophthalmology, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Tianxiang Huang Johnson & Johnson, Code F (Financial Support); Takenori Inomata Santen Pharmaceutical Co., Ltd., Code C (Consultant/Contractor), InnoJin, Inc., Code E (Employment), Novartis Pharma KK, Santen Pharmaceutical Co., Ltd., Lion Corporation, Sony Network Communications Inc., SEED Co., Ltd.  Johnson & Johnson, Shin Nippon Biomedical Laboratories, Ltd.  IBM Japan, Ltd. Kandenko co., Ltd., Code F (Financial Support), Renatech Co., Ltd., InnoJin, Inc.  , Code P (Patent); Koji Kitazawa None; Shokirova Hurramhon None; yuki moroka Johnson & Johnson, Code F (Financial Support); MAKO OKAMOTO None; Yuichi Okumura None; Maria Miura None; Keiichi Fujimoto Johnson & Johnson, Code F (Financial Support); Gaku Ishida None; Shintaro Nakao Code F: Kowa Company. Ltd., Mitsubishi Tanabe Pharma Corporation, Alcon Japan, Ltd., Santen Pharmaceutical Co., Ltd., Machida Endoscope Co., Ltd., Wakamoto Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Senju Pharmaceutical Co., Ltd. Nippon Boehringer Ingelheim Co., Ltd., Chugai Pharmaceutical Co., Ltd., Hoya Corporation, and Novartis Pharma K.K., Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3681. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tianxiang Huang, Takenori Inomata, Koji Kitazawa, Shokirova Hurramhon, yuki moroka, MAKO OKAMOTO, Yuichi Okumura, Maria Miura, Keiichi Fujimoto, Gaku Ishida, Shintaro Nakao; Gene Expression Changes on the Ocular Surface Cellular Aging. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3681.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To examine gene expression changes on the ocular surface associated with aging using middle-aged mice.

Methods : Tear secretion was measured by a phenol red test and corneal fluorescein staining score (CFS) was measured using 0.5% sodium fluorescein and slit-lamp examination respectively, in adult mice (8-12 weeks old, C57BL6, female) and middle-aged mice (48-55 weeks old, C57BL6, female). Samples of corneal, conjunctival, and cervical lymph nodes from each group were collected for the comparative analysis of gene expression in cell markers associated with aging (p16 and p21 variant 2) by real-time PCR, as well as differentially expressed gene (DEG) analysis and Gene Ontology analysis by RNA sequencing.

Results : A significant increase in tear secretion was observed in the middle-aged group compared to the adult group (P=0.023). No significant difference was found in CFS between the two groups. In the middle-aged group, there was an increase in gene expression of p16 in the cornea and cervical lymph nodes (P =0.002 and P =0.039, respectively), and an increase in gene expression of p21 variant 2 in the cervical lymph nodes (P =0.031). DEG analysis by RNA sequencing identified characteristic DEGs of the middle-aged group when compared to control: cornea, 128 genes (up-regulated DEG; 23 genes, down-regulated DEG; 105 genes); conjunctiva, 194 genes (up-regulated DEG; 41 genes, down-regulated DEG; 153 genes); cervical lymph nodes, 678 genes (up-regulated DEG; 385 genes, down-regulated DEG; 293 genes). Gene Ontology analysis identified Go Terms related to extracellular matrix, cell adhesion, angiogenesis regulation, calcification in the cornea; keratinization in the conjunctiva; and extracellular matrix, innate immunity, and mucosal immunity in the cervical lymph nodes in the middle-aged group compared to the adult group.
Conclusion: This study revealed tissue reorganization, cellular interaction, and immune environment changes may be major contributors to cellular aging of the ocular surface.This study revealed tissue reorganization, cellular interaction, and immune environment changes may be major contributors to cellular aging of the ocular surface.

Conclusions : This study revealed tissue reorganization, cellular interaction, and immune environment changes may be major contributors to cellular aging of the ocular surface.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×